These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

366 related items for PubMed ID: 18672636

  • 1. Bone mineral density and body composition in prepubertal and adolescent patients with the classical form of 21-hydroxylase deficiency.
    Sahakitrungruang T, Wacharasindhu S, Supornsilchai V, Srivuthana S, Kingpetch K.
    J Med Assoc Thai; 2008 May; 91(5):705-10. PubMed ID: 18672636
    [Abstract] [Full Text] [Related]

  • 2. Bone mineral density and body composition in congenital adrenal hyperplasia.
    Cameron FJ, Kaymakci B, Byrt EA, Ebeling PR, Warne GL, Wark JD.
    J Clin Endocrinol Metab; 1995 Jul; 80(7):2238-43. PubMed ID: 7608286
    [Abstract] [Full Text] [Related]

  • 3. Bone mineral density in girls with classical congenital adrenal hyperplasia due to CYP21 deficiency.
    Elnecave RH, Kopacek C, Rigatto M, Keller Brenner J, Sisson de Castro JA.
    J Pediatr Endocrinol Metab; 2008 Dec; 21(12):1155-62. PubMed ID: 19189689
    [Abstract] [Full Text] [Related]

  • 4. Effect of long-term glucocorticoid therapy on bone mineral density of the patients with congenital adrenal hyperplasia.
    Ünal S, Alikaşifoğlu A, Özön A, Gönç N, Kandemir N.
    Turk J Pediatr; 2020 Dec; 62(3):359-366. PubMed ID: 32558409
    [Abstract] [Full Text] [Related]

  • 5. Reduced bone mineral density and increased bone metabolism rate in young adult patients with 21-hydroxylase deficiency.
    Sciannamblo M, Russo G, Cuccato D, Chiumello G, Mora S.
    J Clin Endocrinol Metab; 2006 Nov; 91(11):4453-8. PubMed ID: 16926248
    [Abstract] [Full Text] [Related]

  • 6. Classical congenital adrenal hyperplasia due to 21-hydroxylase deficiency: a cross-sectional study of factors involved in bone mineral density.
    de Almeida Freire PO, de Lemos-Marini SH, Maciel-Guerra AT, Morcillo AM, Matias Baptista MT, de Mello MP, Guerra G.
    J Bone Miner Metab; 2003 Nov; 21(6):396-401. PubMed ID: 14586796
    [Abstract] [Full Text] [Related]

  • 7. Fractures and bone mineral density in adult women with 21-hydroxylase deficiency.
    Falhammar H, Filipsson H, Holmdahl G, Janson PO, Nordenskjöld A, Hagenfeldt K, Thorén M.
    J Clin Endocrinol Metab; 2007 Dec; 92(12):4643-9. PubMed ID: 17878254
    [Abstract] [Full Text] [Related]

  • 8. Bone mineral density, bone markers, and fractures in adult males with congenital adrenal hyperplasia.
    Falhammar H, Filipsson Nyström H, Wedell A, Brismar K, Thorén M.
    Eur J Endocrinol; 2013 Mar; 168(3):331-41. PubMed ID: 23211577
    [Abstract] [Full Text] [Related]

  • 9. Bone turnover and bone mineral density in patients with congenital adrenal hyperplasia.
    Guo CY, Weetman AP, Eastell R.
    Clin Endocrinol (Oxf); 1996 Nov; 45(5):535-41. PubMed ID: 8977749
    [Abstract] [Full Text] [Related]

  • 10. [Estimation of influence of congenital-adrenal hyperplasia treatment on bone mineralisation evaluated with densitometry].
    Romanowska H, Krzywińska-Zdeb E, Giżewska M, Kotkowiak L, Safranow K, Horodnicka-Józwa A, Petriczko E, Krupa B, Walczak M.
    Pediatr Endocrinol Diabetes Metab; 2012 Nov; 18(1):21-6. PubMed ID: 22525687
    [Abstract] [Full Text] [Related]

  • 11. Bone mineral density in prepubertal and in adolescent and young adult patients with the salt-wasting form of congenital adrenal hyperplasia.
    Gussinyé M, Carrascosa A, Potau N, Enrubia M, Vicens-Calvet E, Ibáñez L, Yeste D.
    Pediatrics; 1997 Oct; 100(4):671-4. PubMed ID: 9310523
    [Abstract] [Full Text] [Related]

  • 12. Correlation of Bone Mineral Parameters with Anthropometric Measurements and the Effect of Glucocorticoids on Bone Mineral Parameters in Congenital Adrenal Hyperplasia.
    Ganesh R, Suresh N, Janakiraman L, Ravikumar K.
    Indian J Pediatr; 2016 Feb; 83(2):126-30. PubMed ID: 26223873
    [Abstract] [Full Text] [Related]

  • 13. Impact of total cumulative glucocorticoid dose on bone mineral density in patients with 21-hydroxylase deficiency.
    Chakhtoura Z, Bachelot A, Samara-Boustani D, Ruiz JC, Donadille B, Dulon J, Christin-Maître S, Bouvattier C, Raux-Demay MC, Bouchard P, Carel JC, Leger J, Kuttenn F, Polak M, Touraine P, Centre des Maladies Endocriniennes Rares de la Croissance and Association Surrénales.
    Eur J Endocrinol; 2008 Jun; 158(6):879-87. PubMed ID: 18390993
    [Abstract] [Full Text] [Related]

  • 14. Use of an aromatase inhibitor in children with congenital adrenal hyperplasia: Impact of anastrozole on bone mineral density and visceral adipose tissue.
    Halper A, Sanchez B, Hodges JS, Dengel DR, Petryk A, Sarafoglou K.
    Clin Endocrinol (Oxf); 2019 Jul; 91(1):124-130. PubMed ID: 31070802
    [Abstract] [Full Text] [Related]

  • 15. Bone mineral density and body composition in children with congenital adrenal hyperplasia.
    Halper A, Sanchez B, Hodges JS, Kelly AS, Dengel D, Nathan BM, Petryk A, Sarafoglou K.
    Clin Endocrinol (Oxf); 2018 Jun; 88(6):813-819. PubMed ID: 29460378
    [Abstract] [Full Text] [Related]

  • 16. Bone Mass in Young Patients with Congenital Adrenal Hyperplasia due to 21-Hydroxylase Deficiency.
    Espinosa Reyes TM, Leyva González G, Domínguez Alonso E, Falhammar H.
    Horm Res Paediatr; 2021 Jun; 94(1-2):1-8. PubMed ID: 34044395
    [Abstract] [Full Text] [Related]

  • 17. Bone density in young patients with congenital adrenal hyperplasia.
    Mora S, Saggion F, Russo G, Weber G, Bellini A, Prinster C, Chiumello G.
    Bone; 1996 Apr; 18(4):337-40. PubMed ID: 8726391
    [Abstract] [Full Text] [Related]

  • 18. The effect of glucocorticoid replacement therapy on bone mineral density in children with congenital adrenal hyperplasia.
    Cetinkaya S, Kara C.
    J Pediatr Endocrinol Metab; 2011 Apr; 24(5-6):265-9. PubMed ID: 21823521
    [Abstract] [Full Text] [Related]

  • 19. Long-term corticosteroid replacement and bone mineral density in adult women with classical congenital adrenal hyperplasia.
    King JA, Wisniewski AB, Bankowski BJ, Carson KA, Zacur HA, Migeon CJ.
    J Clin Endocrinol Metab; 2006 Mar; 91(3):865-9. PubMed ID: 16278269
    [Abstract] [Full Text] [Related]

  • 20. Normal bone health in young adults with 21-hydroxylase enzyme deficiency undergoing glucocorticoid replacement therapy.
    Borges JH, de Oliveira DM, de Lemos-Marini SHV, Geloneze B, Guerra-Júnior G, Gonçalves EM.
    Osteoporos Int; 2022 Jan; 33(1):283-291. PubMed ID: 34406442
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 19.